You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
哈三聯(002900.SZ)收到換髮《藥品生產許可證》
格隆匯 12-30 16:58

格隆匯 12 月 30日丨哈三聯(002900.SZ)公佈,公司原《藥品生產許可證》將於2020年12月31日到期。近日,公司收到哈爾濱新區管理委員會行政審批局換髮的《藥品生產許可證》,換髮後的《藥品生產許可證》基本信息如下:

企業名稱:哈爾濱三聯藥業股份有限公司;許可證編號:黑20160119;社會信用代碼:91230100607168790X;分類碼:AhzCh;註冊地址:哈爾濱市利民開發區北京路;法定代表人:秦劍飛;企業負責人:秦劍飛;質量負責人:關成山;

生產地址和生產範圍:哈爾濱市利民開發區北京路:大容量注射劑(聚丙烯輸液瓶,玻璃輸液瓶,多層共擠輸液用袋,多腔室袋)、沖洗劑,小容量注射劑(玻璃安瓿、聚丙烯安瓿)、吸入液體制劑,片劑、膠囊劑、顆粒劑、散劑、口服混懸劑,凍乾粉針劑、生化提取,小容量注射劑為(抗腫瘤藥,非最終滅菌)、凍乾粉針劑(為抗腫瘤藥),口崩片(凍幹)***、綏化市蘭西經濟開發區哈三聯路中段:生化提取***、哈爾濱市利民開發區同盛路利民大道庫房:-***0:、貼膏劑(氟比洛芬凝膠貼膏)***;有效期至:2025年12月31日。

此次《藥品生產許可證》換髮是基於原證即將到期,取得新證確保了公司正常生產經營活動。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account